Please login to the form below

Not currently logged in
Email:
Password:

patient advocacy

This page shows the latest patient advocacy news and features for those working in and with pharma, biotech and healthcare.

Clinigen launches educational programme for rare disease patients and organisations

Clinigen launches educational programme for rare disease patients and organisations

Carole Scrafton, director of Flutters &Strutters Patient Advocacy Organisation, said: "Education and training across multiple stakeholders, including patient advocacy groups, healthcare organisations, and healthcare professionals, is key to ensuring

Latest news

More from news
Approximately 3 fully matching, plus 114 partially matching documents found.

Latest Intelligence

  • Amplifying the patient voice Amplifying the patient voice

    For example, while planning a recent disease awareness campaign for sickle cell, a patient advisory board meeting, along with discussions with the leading patient advocacy group, revealed important insights around the ... Peer-to-peer dialogue can

  • LifeArc to launch rare disease centres across the UK LifeArc to launch rare disease centres across the UK

    We will actively seek partnerships with other charities, academic institutions, industry and patient advocacy groups, forming a network of dedicated individuals and organisations pursuing the same mission – to transform the lives ... In all our

  • The five ‘innovation areas’ driving success in chronic diseases The five ‘innovation areas’ driving success in chronic diseases

    Innovative routes of administration can also pave the way to reaching wider patient populations. ... for clinical trials or working with medical societies and patient advocacy groups to increase awareness.

  • Improvement in rare disease diagnosis and care Improvement in rare disease diagnosis and care

    The prevailing shift toward patient-centred care coordination endeavours to tackle these obstacles head-on. ... This unfulfilled need continues to take precedence within the agenda of numerous rare disease patient advocacy groups.

  • The importance of accelerating clinical trial diversity The importance of accelerating clinical trial diversity

    So is beginning an open-ended conversation with community or patient advocacy groups. ... There’s still a lot of groundwork to be put in with patient advocacy groups to achieve meaningful and sustainable change.”.

More from intelligence
Approximately 0 fully matching, plus 66 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 17 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 16 fully matching, plus 72 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
AMICULUM

AMICULUM is an independent family of 11 branded agencies that deliver communications and consultancy services to pharmaceutical, biotechnology and health...

Latest intelligence

Clinical Trials Investigator and Patient Engagement Planning: A Customer Story
...
New Playbook Alert: Virtual Patient Engagement
...
Millennials: the wellness generation
Looking at the results from a global healthcare research study focusing on the patients of the future...